DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Summary for Patent: 8,334,265
|Title:||Method of treatment of photodermatoses|
|Abstract:||This invention relates to a method for prophylactic or therapeutic treatment of photodermatoses that are caused or exacerbated by or associated with UVR exposure in a subject, particularly a human subject, which comprises the step of administering to said subject an amount of an alpha-MSH analogue effective to reduce the photosensitivity of the skin of the subject.|
|Inventor(s):||Wolgen; Philippe (Melbourne, AU)|
|Assignee:||Clinuvel Pharmaceuticals Limited (Melbourne, Victoria, AU)|
1. A method for treating a human subject suffering from photodermatoses that are caused or exacerbated by or associated with ultraviolet radiation (UVR) exposure which
comprises the step of administering to said subject an amount of [Nle.sup.4, D-Phe.sup.7]-alpha-melanocyte stimulating hormone (alpha-MSH) effective to reduce the photosensitivity of the skin of the subject.
2. The method of claim 1, wherein the photodermatosis is erythropoietic photoporphyria (EPP).
3. The method of claim 1, wherein the photodermatosis is solar urticaria (SU).
4. The method of claim 1, wherein the photodermatosis is polymorphous light eruption (PLE).
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.